Advertisement
Integer Holdings Corporation (ITGR)
NYSE - Nasdaq Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 88.90 |
| Open | 88.88 |
| Bid | 89.07 x 1000 |
| Ask | 89.98 x 800 |
| Day's Range | 88.07 - 90.61 |
| 52 Week Range | 61.85 - 96.17 |
| Volume | |
| Avg. Volume | 233,982 |
| Market Cap | 2.984B |
| Beta (5Y Monthly) | 1.08 |
| PE Ratio (TTM) | 37.00 |
| EPS (TTM) | 2.42 |
| Earnings Date | Feb 14, 2024 - Feb 19, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 95.00 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-22% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for ITGR
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Integer Holdings CorporationAnalyst Report: Integer Holdings CorpBased in Plano, Texas, Integer Holdings is a developer and manufacturer of medical devices and components. Its Medical business includes portable medical, cardio & vascular, and cardiac and neuromodulation products. Its Non-Medical division includes the Electrochem product line, which develops batteries for use in the energy, military, and environmental markets. ITGR shares are a component of the Russell 2000 Index. The company has approximately 7,500 employees.RatingFair ValueEconomic Moatlast monthArgus Research
ZacksBD's (BDX) Novel Blood Collection System MiniDraw Gets FDA Nod
BD's (BDX) FDA approval for MiniDraw will likely reshape diagnostic testing by providing a unique design that offers blood collection at any convenient location with reduced volume.
ZacksAMN Healthcare's (AMN) New Tie-Up to Boost Patient Outcome
AMN Healthcare's (AMN) collaboration is likely to bolster its portfolio of products and simplify the language procurement process for customers.
ZacksHere's Why You Should Retain OPKO Health (OPK) Stock for Now
OPKO Health's (OPK) potential in Rayaldee raises optimism about the stock.
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.